Trial Profile
Basic immunization against TBE in persons over fifty years with FSME-IMMUN Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Pharmacodynamics
- Acronyms PRIMER
- Sponsors Baxter Corporation
- 12 Nov 2012 Status changed from planning to active, no longer recruiting as reported by German Clinical Trials Register.
- 20 Feb 2012 New trial record